Search Results

There are 219326 results for: content related to: Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study

  1. Environmental fate and chemistry of raloxifene hydrochloride

    Environmental Toxicology and Chemistry

    Volume 21, Issue 4, April 2002, Pages: 729–736, Jerold Scott Teeter and Roger D. Meyerhoff

    Article first published online : 5 NOV 2009, DOI: 10.1002/etc.5620210407

  2. You have free access to this content
    Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

    Journal of Bone and Mineral Research

    Volume 28, Issue 4, April 2013, Pages: 807–815, Mickael Hiligsmann, Wafa Ben Sedrine and Jean-Yves Reginster

    Article first published online : 18 MAR 2013, DOI: 10.1002/jbmr.1819

  3. You have free access to this content
    Comparative Effects of Estrogen and Raloxifene on B Lymphopoiesis and Bone Loss Induced by Sex Steroid Deficiency in Mice

    Journal of Bone and Mineral Research

    Volume 15, Issue 3, March 2000, Pages: 541–549, Yoshiko Onoe, Chisato Miyaura, Masako Ito, Hiroaki Ohta, Shiro Nozawa and Tatsuo Suda

    Article first published online : 18 FEB 2010, DOI: 10.1359/jbmr.2000.15.3.541

  4. You have free access to this content
    Raloxifene Treatment Is Associated With Increased Serum Estradiol and Decreased Bone Remodeling in Healthy Middle-Aged Men With Low Sex Hormone Levels

    Journal of Bone and Mineral Research

    Volume 19, Issue 9, September 2004, Pages: 1518–1524, Brigitte Uebelhart, François Herrmann, Imre Pavo, Michael W Draper and René Rizzoli

    Article first published online : 3 MAY 2004, DOI: 10.1359/JBMR.040503

  5. You have free access to this content
    ASBMR 25th Annual Meeting M001–M483

    Journal of Bone and Mineral Research

    Volume 18, Issue S1, 2003, Pages: S285–S393,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650181306

  6. You have free access to this content
    Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

    Journal of Bone and Mineral Research

    Volume 19, Issue 8, August 2004, Pages: 1270–1275, Elizabeth Barrett-Connor, Jane A Cauley, Pandurang M Kulkarni, Andreas Sashegyi, David A Cox and Mary Jane Geiger

    Article first published online : 12 APR 2004, DOI: 10.1359/JBMR.040406

  7. You have free access to this content
    Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro

    British Journal of Pharmacology

    Volume 152, Issue 2, September 2007, Pages: 223–229, F P Leung, L M Yung, H S Leung, C L Au, X Yao, P M Vanhoutte, I Laher and Y Huang

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707387

  8. You have free access to this content
    Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics

    British Journal of Clinical Pharmacology

    Volume 67, Issue 4, April 2009, Pages: 437–444, Jurij Trontelj, Janja Marc, Andrej Zavratnik, Marija Bogataj and Aleš Mrhar

    Article first published online : 21 JAN 2009, DOI: 10.1111/j.1365-2125.2009.03363.x

  9. You have free access to this content
    Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

    Journal of Bone and Mineral Research

    Volume 17, Issue 1, January 2002, Pages: 1–10, Somnath Sarkar, Bruce H. Mitlak, Mayme Wong, John L. Stock, Dennis M. Black and Kristine D. Harper

    Article first published online : 1 JAN 2002, DOI: 10.1359/jbmr.2002.17.1.1

  10. Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 3, May 2002, Pages: 166–176, N. K. Wenger

    Article first published online : 30 MAY 2002, DOI: 10.1046/j.1463-1326.2002.00208.x

  11. RALOXIFENE, TAMOXIFEN AND VASCULAR TONE

    Clinical and Experimental Pharmacology and Physiology

    Volume 34, Issue 8, August 2007, Pages: 809–813, Fung Ping Leung, Suk Ying Tsang, Chi Ming Wong, Lai Ming Yung, Yau Chi Chan, Hok Sum Leung, Xiaoqiang Yao and Yu Huang

    Article first published online : 26 JUN 2007, DOI: 10.1111/j.1440-1681.2007.04684.x

  12. An update on raloxifene

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 502–503, M.W. Draper

    Article first published online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00680.x

  13. You have free access to this content
    Bone Histomorphometric and Biochemical Marker Results of a 2-Year Placebo-Controlled Trial of Raloxifene in Postmenopausal Women

    Journal of Bone and Mineral Research

    Volume 17, Issue 2, February 2002, Pages: 341–348, Susan M. Ott, Anna Oleksik, Yili Lu, Kristine Harper and Paul Lips

    Article first published online : 1 FEB 2002, DOI: 10.1359/jbmr.2002.17.2.341

  14. You have free access to this content
    Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX® versus EVISTA®Comparison Trial) International

    Journal of Internal Medicine

    Volume 255, Issue 4, April 2004, Pages: 503–511, P. N. Sambrook, 1 P. Geusens, 2 C. Ribot, 3 J. A. Solimano, 4 J. Ferrer-Barriendos, 5 K. Gaines, 6 N. Verbruggen and 6 M. E. Melton 6

    Article first published online : 22 MAR 2004, DOI: 10.1111/j.1365-2796.2004.01317.x

  15. Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits

    Clinical Endocrinology

    Volume 52, Issue 2, February 2000, Pages: 225–233, Nina Hannover Bjarnason, Jens Haarbo, Inger Byrjalsen, Raymond F. Kauffman, Mary Pat Knadler and Claus Christiansen

    Article first published online : 9 OCT 2006, DOI: 10.1046/j.1365-2265.2000.00919.x

  16. You have free access to this content
    ASBMR 26th Annual Meeting SA001–SA589

    Journal of Bone and Mineral Research

    Volume 19, Issue S1, 2004, Pages: S108–S204,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650191304

  17. You have free access to this content
    Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current

    British Journal of Pharmacology

    Volume 142, Issue 1, May 2004, Pages: 89–96, Reginald Liew, Mark A Stagg, Kenneth T MacLeod and Peter Collins

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705736

  18. You have free access to this content
    Raloxifene protects endothelial cell function against oxidative stress

    British Journal of Pharmacology

    Volume 155, Issue 3, October 2008, Pages: 326–334, C M Wong, L M Yung, F P Leung, S-Y Tsang, C L Au, Z-Y Chen, X Yao, C H K Cheng, C-W Lau, M Gollasch and Y Huang

    Article first published online : 29 JAN 2009, DOI: 10.1038/bjp.2008.262

  19. You have free access to this content
    Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

    Journal of Bone and Mineral Research

    Volume 20, Issue 9, September 2005, Pages: 1514–1524, Ethel S Siris, Steven T Harris, Richard Eastell, Jose R Zanchetta, Stefan Goemaere, Adolfo Diez-Perez, John L Stock, Jingli Song, Yongming Qu, Pandurang M Kulkarni, Suresh R Siddhanti, Mayme Wong and Steven R Cummings

    Article first published online : 16 MAY 2005, DOI: 10.1359/JBMR.050509

  20. You have free access to this content
    Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis

    Arthritis & Rheumatism

    Volume 56, Issue 10, October 2007, Pages: 3261–3270, Caroline Jochems, Ulrika Islander, Anna Kallkopf, Marie Lagerquist, Claes Ohlsson and Hans Carlsten

    Article first published online : 28 SEP 2007, DOI: 10.1002/art.22873